Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers-Reference-Cited by-同舟云学术

Radiofrequency ablation and transarterial chemoembolisation as first-line treatment for recurrent hepatocellular carcinoma or isolated intrahepatic recurrent hepatocellular carcinoma in transplanted livers

Published:2017-02 Issue:2 Volume:72 Page:141-149
ISSN:0009-9260
Container-title:Clinical Radiology
language:en
Short-container-title:Clinical Radiology

Author:

Kim S.S.,Kang T.W.,Song K.D.,Cho S.K.,Lee M.W.,Rhim H.,Sinn D.H.,Jung S.-H.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Reference28 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2012

2. Liver transplantation for hepatocellular carcinoma;Chan;Liver Cancer,2013

3. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis;Mazzaferro;N Engl J Med,1996

4. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival;Yao;Hepatology,2001

5. Management of recurrent hepatocellular carcinoma after liver transplant;Chok;World J Hepatol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in recurrent hepatocellular carcinoma therapy;World Journal of Hepatology;2023-04-27

2. Predictive Factors for the Resectable Type of Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplant;Transplantation Proceedings;2023-01

3. Effectiveness of radiofrequency ablation versus transarterial chemoembolization for recurrent hepatocellular carcinoma: A meta-analysis;Acta Radiologica Open;2022-03

4. Quantitative Ultrasound Elastography Methods in Focal Liver Lesions Including Hepatocellular Carcinoma;Ultrasound Quarterly;2021-06

5. Efficacy and safety of apatinib combined with transarterial chemoembolization (TACE) in treating patients with recurrent hepatocellular carcinoma;Annals of Translational Medicine;2020-12